Lanadelumab for preventing recurrent attacks of hereditary angioedema.

Research output: Book/Report › Commissioned Report

Abstract

Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

Original language	English
Publisher	National Institute for Health and Care Excellence (NICE)
Publication status	Published - 2019

@book{1cf144e83d9340f3b28aef8db9ad1e00,

title = "Lanadelumab for preventing recurrent attacks of hereditary angioedema.",

abstract = "Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence",

author = "Clare Robertson and Andrew Walker and Elisabet Jacobsen and Lorna Aucott and Richard Herriot and Graham Scotland and Miriam Brazzelli",

year = "2019",

language = "English",

publisher = "National Institute for Health and Care Excellence (NICE)",

}

TY - BOOK

T1 - Lanadelumab for preventing recurrent attacks of hereditary angioedema.

AU - Robertson, Clare

AU - Walker, Andrew

AU - Jacobsen, Elisabet

AU - Aucott, Lorna

AU - Herriot, Richard

AU - Scotland, Graham

AU - Brazzelli, Miriam

PY - 2019

Y1 - 2019

N2 - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

AB - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

M3 - Commissioned Report

BT - Lanadelumab for preventing recurrent attacks of hereditary angioedema.

PB - National Institute for Health and Care Excellence (NICE)

ER -